ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1198 • 2019 ACR/ARP Annual Meeting

    Practice Based Education Program to Increase Vaccination Rate in Patients on Immunotherapeutic Agents

    Andrea Soliman1, Soorya Aggarwal 1, Kyle Kreitman 1, Kourtney Erickson 1, Abdul Aleem 1 and Marie O'Brien 1, 1Lehigh Valley Health Network, Allentown, PA

    Background/Purpose: Immunosuppressive agents have changed the course of debilitating autoimmune conditions. Despite their advantages, these agents come with risk of vaccine preventable infections.1 Multiple organizations recommend…
  • Abstract Number: 1199 • 2019 ACR/ARP Annual Meeting

    Improving Rates of Cervical Cancer Screening and HPV Vaccination in Patients with Lupus

    Nancy Desai1, Hanni Menn-Josephy 1, Ramon Bonegio 1, Christina Lam 1, Anna Kancharla 1 and Michael York 1, 1Boston Medical Center, Boston

    Background/Purpose: Patients with lupus have higher rates of cervical dysplasia and pre-malignant cervical lesions. At our institution, an urban referral center for patients with lupus, rates…
  • Abstract Number: 1200 • 2019 ACR/ARP Annual Meeting

    Influenza Vaccination Rates Among Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis on Immunosuppressive Therapy: Findings from a Large Public Hospital

    Judith Aniekwena1, Titilope Olanipekun 2 and Valery Effoe 2, 1Morehouse School of Medicine, Atlanta, GA, 2Morehouse School of Medicine, Atlanta

    Background/Purpose: Influenza infection constitutes a significant cause of morbidity and mortality in patients living with Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA). The risk…
  • Abstract Number: 1201 • 2019 ACR/ARP Annual Meeting

    Are We Meeting Benchmarks for Wait Times to Pediatric Rheumatology Care for Juvenile Idiopathic Arthritis (JIA)?

    Claire Barber1, Natalie Shiff 2, Cheryl Barnabe 3, Susanne Benseler 3, Ricky Chin 3, Nicole Johnson 3, Nadia Luca 3, Paivi Miettunen 4, Marinka Twilt 3, Dwaraka Veeramreddy 3 and Heinrike Schmeling 5, 1University of Calgary, Calgary, Canada, 2University of Florida, Gainesville, FL, 3University of Calgary, Calgary, AB, Canada, 4Alberta Children's Hospital, Calgary, ON, Canada, 5Pediatric Rheumatology Collaborative Study Group (PRCSG), Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Wait time to pediatric rheumatology care for patients with Juvenile Idiopathic Arthritis (JIA) is a nationally endorsed quality measure in Canada. Target wait times…
  • Abstract Number: 1202 • 2019 ACR/ARP Annual Meeting

    Testing Rheumatoid Arthritis Performance Measures to Optimize Treat to Target Strategies

    Claire Barber1, Dianne Mosher 2, Glen Hazlewood 1, Paul MacMullan 2, Cheryl Barnabe 2, Victoria Bohm 2, James Rankin 2, Joanne Homik 3, Kelly English 4, Karen Tsui 5, Bo Pan 6, Martina Stevenson 2, Namneet Sandhu 2, Andrea Emrick 2, Liam Martin 1, Caylib Durand 2, Michelle Jung 2 and Diane Lacaille 7, 1University of Calgary, Calgary, Canada, 2University of Calgary, Calgary, AB, Canada, 3University of Alberta, Edmonton, Canada, 4Arthritis Patient Advocacy Board, Vancouver, BC, Canada, 5Arthritis Patient Advisory Board, Toronto, ON, Canada, 6University of Alberta, Edmonton, AB, Canada, 7Arthritis Research Canada and University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: The purpose of this study was to operationalize and report on 3 Rheumatoid Arthritis (RA) performance measures previously identified in the Patient-Centered Framework for…
  • Abstract Number: 1203 • 2019 ACR/ARP Annual Meeting

    Psychometric Properities of the Patient Related Outcome Measure FACIT-Fatigue in Rheumatic Arthritis and Psoriatic Arthritis: A Literature Review

    M. Elaine Husni1, Mark Kosinski 2, Regina Rendas-Baum 2, Shelly Kafka 3, Chenglong Han 4, Eric K H Chan 4, Elizabeth Hsia 5 and Arthur Kavanaugh 6, 1Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 2Optum, Johnston, RI, 3Janssen Scientific Affairs, LLC, Horsham, PA, 4Janssen Research & Development, LLC, Spring House, PA, 5Janssen Research & Development, LLC/University of Pennsylvania, Spring House/Philadelphia, PA, 6University of California, San Diego School of Medicine, La Jolla, CA

    Background/Purpose: Fatigue is an important patient reported outcome in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) research.  FACIT-Fatigue is a 13-item patient reported outcome (PRO)…
  • Abstract Number: 1204 • 2019 ACR/ARP Annual Meeting

    Improvements in Health-Related Quality of Life in Psoriatic Arthritis Patients Treated with Intravenous Golimumab, an Anti-TNFα Monoclonal Antibody: 1-Year Results of a Phase III Trial

    M. Elaine Husni1, Diane Harrison 2, Elizabeth Hsia 3, Eric K H Chan 2, Chenglong Han 2, Shelly Kafka 4, Kim Hung Lo 2, Lilianne Kim 2 and Arthur Kavanaugh 5, 1Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 2Janssen Research & Development, LLC, Spring House, PA, 3Janssen Research & Development, LLC/University of Pennsylvania, Spring House/Philadelphia, PA, 4Janssen Scientific Affairs, LLC, Horsham, PA, 5University of California, San Diego School of Medicine, La Jolla, CA

    Background/Purpose: In the randomized, phase 3, GO-VIBRANT study, more patients with psoriatic arthritis (PsA) achieved ACR 20/50/70 after 24 weeks IV treatment with the anti-TNFa…
  • Abstract Number: 1205 • 2019 ACR/ARP Annual Meeting

    Real-World Remission Outcomes in the First Year Following RA Diagnosis Vary Considerably with the Disease Activity Index Used and a Sizable Proportion Have Persistent Active Disease Across All Measures: Results from the Canadian Early Arthritis Cohort (CATCH)

    Orit Schieir1, Susan J. Bartlett 2, Marie-France Valois 3, Louis Bessette 4, Gilles Boire 5, Glen Hazlewood 6, Carol Hitchon 7, Edward Keystone 8, Janet Pope 9, Carter Thorne 10, Diane Tin 11, Vivian Bykerk 12 and Canadian Early Arthritis Cohort (CATCH) Investigators 13, 1University of Toronto, Montreal, Canada, 2McGill University, Montreal, QC, Canada, 3McGill University, Montreal, Canada, 4Laval University, Quebec City, QC, Canada, 5Sherbrooke University, Sherbrooke, QC, Canada, 6University of Calgary, Calgary, Canada, 7University of Manitoba, Winnipeg, Canada, 8Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 9Western University, London, ON, Canada, 10Southlake Regional Health Centre, Newmarket, ON, Canada, 11Southlake Regional Health Centre, Newmarket, Canada, 12Hospital for Special Surgery, New York City, NY, 13Canadian Early Arthritis Cohort (CATCH) Study, Toronto, Canada

    Background/Purpose: Early RA diagnosis and initiation of DMARDs following a treat-to -target approach is recommended to optimize remission outcomes. Several RA disease activity indices are…
  • Abstract Number: 1206 • 2019 ACR/ARP Annual Meeting

    Performance of the Patient-Reported Outcomes Measurement Information System 29 (PROMIS-29) Item Profile in a Cohort of Australians with RA, OA and Other Inflammatory Arthritic Conditions

    Geraldine Hassett 1, Dana Gerogevsky 2, Joseph Descallar 3, Ray Fang 4, Frank Huang 4 and Kathryn Gibson1, 1Liverpool Hospital, Sydney, New South Wales, Australia, 2Royal Prince Alfred Hospital, Sydney, Australia, 3Ingham Research Institute, Sydney, New South Wales, Australia, 4University of New South Wales, Sydney, New South Wales, Australia

    Background/Purpose: Guarded support for PROMIS-29 assessment in musculoskeletal disease has been reported in RA, OA, FM and SLE patients1. The performance of PROMIS-29 compared to…
  • Abstract Number: 1207 • 2019 ACR/ARP Annual Meeting

    A Quality Improvement Intervention to Reduce 30-Day Hospital Readmission Rates Among Patients with Systemic Lupus Erythematosus

    Emily Bowers1, Melissa Griffith 1, Elena Weinstein 1, Duane Pearson 1 and Jason Kolfenbach 1, 1University of Colorado Department of Rheumatology, Denver, CO

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic immune-mediated disease with significant morbidity and mortality that often requires inpatient hospitalization. SLE has one of the…
  • Abstract Number: 1208 • 2019 ACR/ARP Annual Meeting

    Outpatient Readmission in Rheumatology: A Machine Learning Predictive Model of Patient’s Return to the Clinic

    Luis Rodríguez-Rodríguez1, Alfredo Madrid García 1, Judit Font Urgelles 2, Mario Vega-Barbas 3, Leticia León 4, Dalifer Freites Nuñez 5, Cristina Lajas 6, Esperanza Pato Cour 6, Juan Angel Jover Jover 6, Benjamín Fernández Gutiérrez 7 and lydia Abasolo Alcazar 6, 1Fundación para la Investigación Biomedica, Madrid, Spain, 2HOSPITAL CLINICO SAN CARLOS, MADRID, Madrid, Spain, 3Universidad Politécnica de Madrid, Madrid, Madrid, Spain, 4Fundación para la Investigación Biomedica, Madrid, Madrid, Spain, 5Hospital Clínico San Carlos, MADRID, Spain, 6HOSPITAL CLINICO SAN CARLOS, MADRID, Spain, 7Hospital Clínico San Carlos, Madrid

    Background/Purpose: Readmissions can be defined as the return of a patient to a healthcare setting after a discharge. Attention has been mainly focused on readmissions…
  • Abstract Number: 1209 • 2019 ACR/ARP Annual Meeting

    Patient-reported Outcome Measures in Systemic Lupus Erythematosus: Use in Clinical Practice – Preliminary Results from the Integrate Project

    Gamal Chehab1, Jutta Richter 2, Anna Kernder 1, Chiara Tani 3, Valentina Lorenzoni 4, Elena Elefante 3, Ilaria Palla 5, Sara Cannizzo 6, Salvatore Pirri 6, Isotta Triulzi 5, Leopoldo Trieste 5, Giuseppe Turchetti 5, Marta Mosca 3 and Matthias Schneider 7, 1Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine-University, Duesseldorf, Germany, 2Department and Hiller Research Unit of Rheumatology, Heinrich-Heine University Duesseldorf, Duesseldorf, Nordrhein-Westfalen, Germany, 3Rheumatology Unit, Department of clinical and experimental medicine, University of Pisa, Pisa, Italy, 4Institute of Management , Scuola Superiore Sant'Anna, Pisa, Italy, 5Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy, 6Institute of Management, Scuola Superiore Sant'Anna, Pisa, Toscana, Italy, 7Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany

    Background/Purpose: Due to improved mortality and morbidity in systemic lupus erythematosus (SLE), non-clinical indicators and outcomes, especially patient-reported ones, have become increasingly important in disease…
  • Abstract Number: 1210 • 2019 ACR/ARP Annual Meeting

    Utilization of a Multispecialty Team for the Diagnosis of Giant Cell Arteritis Reduces Patient Morbidity

    Arash Hassantoufighi 1, Rachel Lu-Do1, Mamta Sherchan 1, Christopher Collins 1, Joshpaul Dhillon 2 and Florina Constantinescu 1, 1MedStar Washington Hospital Center, Department of Rheumatology, Washington, DC, 2MedStar Washington Hospital Center, Department of Internal Medicine, Washington, DC

    Background/Purpose: Giant Cell Arteritis (GCA) is an autoimmune vasculitis, most common in older adults with a peak incidence in the seventh decade. The diagnosis is…
  • Abstract Number: 1211 • 2019 ACR/ARP Annual Meeting

    Improving Exercise Counselling of Patients with Inflammatory Arthritis: A Quality Improvement Project

    Anwar Albasri 1, Tariq Al-Araimi 1, Stephanie Gottheil1, Lauren King 1, Sahil Koppikar 2, Justin Shamis 1, Shirley Lake 3 and Gakhal Natasha 1, 1University of Toronto, Toronto, Canada, 2University of Toronto, Markham, ON, Canada, 3Division of Rheumatology, Sunnybrook Hospital, Toronto, ON, Canada

    Background/Purpose: Regular aerobic exercise has been shown to improve inflammatory arthritis (IA) symptoms and may reduce the risk of cardiovascular events observed in these patients.…
  • Abstract Number: 1212 • 2019 ACR/ARP Annual Meeting

    Psychological Profile in Patients with Rheumatic Diseases in China: A Study of HADS Self-assessment with Smart System of Disease Management (SSDM)

    Yongfu Wang1, Jianhong Wu 2, Yasong Li 3, Henglian Wu 4, Yang li 5, Hua Wei 6, Xiaoqi Chen 7, Bin Wu 8, Zhenbin li 9, Jinli Ru 10, Wenqiang Fan 11, Shengguang Li 12, Fang He 13, Yi Zhao 14, Fen Li 15, Bin Wu 16, Feng Wang 17, Miaojia Zhang 18, Lirong Kang 19, Hui Xiao 20, Yuhua Jia 21, Bing Wu 22, Fei Xiao 23 and Hui Song 24, 1The First Affiliated Hospital of BaoTou Medical College, Baotou, Nei Mongol, China (People's Republic), 2Dazhou Central Hospital, Dazhou, Sichuan, China (People's Republic), 3Zhejiang provincial people's hospital, Hangzhou, Zhejiang, China (People's Republic), 4Dongguan donghua hospital, Dongguan, Guangdong, China (People's Republic), 5The Second Affiliated Hospital of Harbin Medical University, Haerbin, China (People's Republic), 6Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), 7Zhongnan Hospital of Wuhan University, wuhan, China (People's Republic), 8The First People's Hospital of Jingzhou, jingzhou, China (People's Republic), 9The 980th Hospital of the PLA Joint Logistic Support Force, shijiazhuang, China (People's Republic), 10The Second Hospital of Shanxi Medical University, Shanxi, Shanxi, China (People's Republic), 11Central Hospital of XinXiang, Xinxiang, Hainan, China (People's Republic), 12Peking University International Hospital, beijing, China (People's Republic), 13Suining Central Hospital, suining, China (People's Republic), 14Xuanwu Hospital, Capital Medical University, Beijing, China, beijing, China (People's Republic), 15The Second Xiangya Hospital of Central South University, changsha, China (People's Republic), 16Chongqing Hospital of Traditional Chinese Medicine, Chongqing, Chongqing, China (People's Republic), 17Central Hospital of Xiangyang, xiangyang, China (People's Republic), 18Jiangsu Province Hospital, The first affiliated hospital of Nanjing medical university, nanjing, China (People's Republic), 19The First Affiliated Hospital of BaoTou Medical College, baotou, China (People's Republic), 20Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), 21Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 22Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), 23Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic), 24Beijing Jishuitan Hospital, Beijing, Beijing, China (People's Republic)

    Background/Purpose: The patients with chronic diseases such as rheumatic diseases suffer from physical pain and/or disability. In addition, psychological morbidities have also been found in…
  • « Previous Page
  • 1
  • …
  • 1018
  • 1019
  • 1020
  • 1021
  • 1022
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology